skip to main content

Content language

Contact us: CRM@email.irandoc.ac.ir

Concept information

... > chemical entity > molecular entity > main group molecular entity > p-block molecular entity > pnictogen molecular entity > nitrogen molecular entity > organonitrogen compound > carboxamide > secondary carboxamide > n-(5-/{[(5-tert-butyl-1,3-oxazol-2-yl)methyl]sulfanyl/}-1,3-thiazol-2-yl)-2-(4-methylpiperazin-1-yl)pyridine-4-carboxamide
organooxygen compound > carboxamide > secondary carboxamide > n-(5-/{[(5-tert-butyl-1,3-oxazol-2-yl)methyl]sulfanyl/}-1,3-thiazol-2-yl)-2-(4-methylpiperazin-1-yl)pyridine-4-carboxamide
... > chemical entity > molecular entity > main group molecular entity > p-block molecular entity > pnictogen molecular entity > nitrogen molecular entity > amide > primary amide > carboxamide > secondary carboxamide > n-(5-/{[(5-tert-butyl-1,3-oxazol-2-yl)methyl]sulfanyl/}-1,3-thiazol-2-yl)-2-(4-methylpiperazin-1-yl)pyridine-4-carboxamide
... > chemical entity > molecular entity > main group molecular entity > p-block molecular entity > pnictogen molecular entity > nitrogen molecular entity > organonitrogen compound > organonitrogen heterocyclic compound > pyridines > n-(5-/{[(5-tert-butyl-1,3-oxazol-2-yl)methyl]sulfanyl/}-1,3-thiazol-2-yl)-2-(4-methylpiperazin-1-yl)pyridine-4-carboxamide
organic heterocyclic compound > organonitrogen heterocyclic compound > pyridines > n-(5-/{[(5-tert-butyl-1,3-oxazol-2-yl)methyl]sulfanyl/}-1,3-thiazol-2-yl)-2-(4-methylpiperazin-1-yl)pyridine-4-carboxamide
organic heterocyclic compound > organic heteromonocyclic compound > pyridines > n-(5-/{[(5-tert-butyl-1,3-oxazol-2-yl)methyl]sulfanyl/}-1,3-thiazol-2-yl)-2-(4-methylpiperazin-1-yl)pyridine-4-carboxamide
... > chemical entity > molecular entity > main group molecular entity > p-block molecular entity > chalcogen molecular entity > sulfur molecular entity > organosulfur compound > organic sulfide > n-(5-/{[(5-tert-butyl-1,3-oxazol-2-yl)methyl]sulfanyl/}-1,3-thiazol-2-yl)-2-(4-methylpiperazin-1-yl)pyridine-4-carboxamide
... > chemical entity > molecular entity > main group molecular entity > p-block molecular entity > chalcogen molecular entity > sulfur molecular entity > organosulfur compound > organosulfur heterocyclic compound > thiazoles > 1,3-thiazoles > n-(5-/{[(5-tert-butyl-1,3-oxazol-2-yl)methyl]sulfanyl/}-1,3-thiazol-2-yl)-2-(4-methylpiperazin-1-yl)pyridine-4-carboxamide
organic heterocyclic compound > organosulfur heterocyclic compound > thiazoles > 1,3-thiazoles > n-(5-/{[(5-tert-butyl-1,3-oxazol-2-yl)methyl]sulfanyl/}-1,3-thiazol-2-yl)-2-(4-methylpiperazin-1-yl)pyridine-4-carboxamide
... > chemical entity > molecular entity > main group molecular entity > p-block molecular entity > pnictogen molecular entity > nitrogen molecular entity > organonitrogen compound > organonitrogen heterocyclic compound > azole > thiazoles > 1,3-thiazoles > n-(5-/{[(5-tert-butyl-1,3-oxazol-2-yl)methyl]sulfanyl/}-1,3-thiazol-2-yl)-2-(4-methylpiperazin-1-yl)pyridine-4-carboxamide
... > organic heterocyclic compound > organonitrogen heterocyclic compound > azole > thiazoles > 1,3-thiazoles > n-(5-/{[(5-tert-butyl-1,3-oxazol-2-yl)methyl]sulfanyl/}-1,3-thiazol-2-yl)-2-(4-methylpiperazin-1-yl)pyridine-4-carboxamide
... > organic aromatic compound > heteroarene > monocyclic heteroarene > azole > thiazoles > 1,3-thiazoles > n-(5-/{[(5-tert-butyl-1,3-oxazol-2-yl)methyl]sulfanyl/}-1,3-thiazol-2-yl)-2-(4-methylpiperazin-1-yl)pyridine-4-carboxamide
... > organic heterocyclic compound > heteroarene > monocyclic heteroarene > azole > thiazoles > 1,3-thiazoles > n-(5-/{[(5-tert-butyl-1,3-oxazol-2-yl)methyl]sulfanyl/}-1,3-thiazol-2-yl)-2-(4-methylpiperazin-1-yl)pyridine-4-carboxamide
... > chemical entity > molecular entity > main group molecular entity > p-block molecular entity > carbon group molecular entity > organic molecular entity > organic amino compound > tertiary amino compound > n-methylpiperazine > n-(5-/{[(5-tert-butyl-1,3-oxazol-2-yl)methyl]sulfanyl/}-1,3-thiazol-2-yl)-2-(4-methylpiperazin-1-yl)pyridine-4-carboxamide
... > chemical entity > molecular entity > main group molecular entity > p-block molecular entity > pnictogen molecular entity > nitrogen molecular entity > organonitrogen compound > organic amino compound > tertiary amino compound > n-methylpiperazine > n-(5-/{[(5-tert-butyl-1,3-oxazol-2-yl)methyl]sulfanyl/}-1,3-thiazol-2-yl)-2-(4-methylpiperazin-1-yl)pyridine-4-carboxamide
... > chemical entity > molecular entity > main group molecular entity > p-block molecular entity > carbon group molecular entity > organic molecular entity > organic amino compound > tertiary amino compound > n-alkylpiperazine > n-methylpiperazine > n-(5-/{[(5-tert-butyl-1,3-oxazol-2-yl)methyl]sulfanyl/}-1,3-thiazol-2-yl)-2-(4-methylpiperazin-1-yl)pyridine-4-carboxamide
... > chemical entity > molecular entity > main group molecular entity > p-block molecular entity > pnictogen molecular entity > nitrogen molecular entity > organonitrogen compound > organic amino compound > tertiary amino compound > n-alkylpiperazine > n-methylpiperazine > n-(5-/{[(5-tert-butyl-1,3-oxazol-2-yl)methyl]sulfanyl/}-1,3-thiazol-2-yl)-2-(4-methylpiperazin-1-yl)pyridine-4-carboxamide

Preferred term

n-(5-/{[(5-tert-butyl-1,3-oxazol-2-yl)methyl]sulfanyl/}-1,3-thiazol-2-yl)-2-(4-methylpiperazin-1-yl)pyridine-4-carboxamide  

Type

  • http://www.irandoc.ac.ir/onto/irandoc-meta/Concept

charge

  • 0

formula

  • C22H28N6O2S2

inchi

  • InChI=1S/C22H28N6O2S2/c1-22(2,3)16-12-24-18(30-16)14-31-19-13-25-21(32-19)26-20(29)15-5-6-23-17(11-15)28-9-7-27(4)8-10-28/h5-6,11-13H,7-10,14H2,1-4H3,(H,25,26,29)

inchikey

  • DKEUNWBAWCANFH-UHFFFAOYSA-N

mass

  • 472.630

monoisotopicmass

  • 472.17152

smiles

  • O=C(C1=CC=NC(N2CCN(CC2)C)=C1)NC3=NC=C(SCC4=NC=C(C(C)(C)C)O4)S3

subset

  • 3_STAR

synonym EXACT

  • N-(5-{[(5-tert-butyl-1,3-oxazol-2-yl)methyl]sulfanyl}-1,3-thiazol-2-yl)-2-(4-methylpiperazin-1-yl)pyridine-4-carboxamide

URI

http://www.irandoc.acir/onto/irandoc/CHEBI:143105

Download this concept: